Oxbow Advisors, LLC Novartis Ag Transaction History

Oxbow Advisors, LLC

$891 Million
Q3 2024

A detailed history of Oxbow Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Oxbow Advisors, LLC holds 25,402 shares of NVS stock, worth $2.66 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

25,402

Previous 25,547 0.57%

Holding current value

$2.66 Million

Previous $2.72 Million 7.43%

% of portfolio

0.33%

Previous 0.36%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$106.13 - $120.89 $15,388 - $17,529	-145 Reduced 0.57%	25,402 $2.92 Million
Q2 2024 Aug 06, 2024	BUY	$92.57 - $107.37 $2.36 Million - $2.74 Million	25,547 New	25,547 $2.72 Million
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $8.11 Million - $9.17 Million	-101,241 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $117,876 - $130,344	-1,479 Reduced 1.44%	101,241 $8.86 Million
Q3 2021 Nov 10, 2021	BUY	$81.78 - $95.14 $328,019 - $381,606	4,011 Added 4.06%	102,720 $8.4 Million
Q2 2021 Aug 04, 2021	BUY	$85.24 - $94.15 $304,306 - $336,115	3,570 Added 3.75%	98,709 $9.01 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $151,886 - $179,116	-1,819 Reduced 1.88%	95,139 $8.13 Million
Q4 2020 Feb 02, 2021	SELL	$78.07 - $94.43 $100,319 - $121,342	-1,285 Reduced 1.31%	96,958 $9.16 Million
Q3 2020 Nov 06, 2020	SELL	$82.14 - $91.0 $73,679 - $81,627	-897 Reduced 0.9%	98,243 $8.54 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $8.02 Million - $9.03 Million	99,140 New	99,140 $8.66 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.

Account

Oxbow Advisors, LLC Novartis Ag Transaction History